INCY logo

INCYTE CORP

INCYNASDAQ
🏆 #468 by market capEarnings Oct 29🧬Biotech
$116.87▲ $0.27 (+0.23%)
🌙 After hours$116.73▼ 0.12%Regular close · extended-hours price shown
🔔
Track INCY
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 0.2%
7d▲ 0.0%
14d▲ 3.2%
30d▼ 5.1%
ytd▲ 18.3%
1y▲ 29.7%
🏦Market Cap
$23.69B
Mid Cap
📈Revenue Growth (YoY)
21.2%
Healthy
📊Gross Margin
92.6%
High
💵FCF Margin
33.0%
Strong
⚖️P/S Ratio
4.1x
Fair
Otter Score
72
Strong
INCY logo

INCYTE CORP

INCY
Analyst Ratings
Price
$116.87
Total
44
Raised
4
Lowered
4
Avg PT
$136.53
H / L
$157 / $104
Institution
TD Cowen
Reiterated · Buy · 2026-10-21
—
—
Truist Securities
Reiterated · Hold · 2026-10-14
—
—
HC Wainwright & Co.
Reiterated · Buy · 2026-10-13
—
—
RBC Capital
Reiterated · Sector Perform · 2026-10-08
$114.00
−2.50%
Stifel
Reiterated · Buy · 2026-10-05
—
—
Wells Fargo
Reiterated · Equal Weight · 2026-10-01
$107.00
−8.40%
JP Morgan
Reiterated · Neutral · 2026-09-28
—
—
Piper Sandler
Reiterated · Overweight · 2026-08-17
$130.00
+11.20%
Mizuho
Reiterated · Outperform · 2026-08-04
—
—
Leerink Partners
Reiterated · Outperform · 2026-08-03
$155.00
+32.60%
Barclays
Reiterated · Overweight · 2026-07-29
$139.00
+18.90%
Guggenheim
Reiterated · Buy · 2026-07-29
$150.00
+28.30%
BMO Capital
Reiterated · Market Perform · 2026-07-29
$130.00
+11.20%
Morgan Stanley
Reiterated · Equal Weight · 2026-07-23
$119.00
+1.80%
UBS
Reiterated · Neutral · 2026-06-26
$127.00
+8.70%
Oppenheimer
Reiterated · Perform · 2026-04-29
$152.00
+30.10%
Jefferies
Downgraded · Buy → Hold · 2026-03-16
$84.00
−28.10%
Evercore ISI Group
Reiterated · In Line · 2026-03-05
—
—
B of A Securities
Reiterated · Buy · 2025-09-04
—
—
Citigroup
Reiterated · Buy · 2025-07-30
$97.00
−17.00%
William Blair
Downgraded · Outperform → Market Perform · 2025-03-18
—
—
Citizens Capital Markets
Reiterated · Market Perform · 2025-03-11
—
—
JMP Securities
Reiterated · Market Perform · 2025-02-11
—
—
Cantor Fitzgerald
Reiterated · Neutral · 2025-01-10
$79.00
−32.40%
Goldman Sachs
Reiterated · Neutral · 2024-10-30
$90.00
−23.00%
Deutsche Bank
Reiterated · Hold · 2024-08-01
$55.00
−52.90%
SVB Leerink
Reiterated · Underperform · 2023-03-20
—
—
Credit Suisse
Reiterated · Buy · 2023-02-16
—
—
Cowen & Co.
Reiterated · Outperform · 2023-02-08
$100.00
−14.40%
Benchmark
Upgraded · Hold → Buy · 2021-07-20
—
—
Guggenheim Securities
Downgraded · Buy → Neutral · 2020-01-02
—
—
Nomura
Reiterated · Buy · 2019-07-31
—
—
Stifel Nicolaus
Reiterated · Hold · 2019-04-11
$157.00
+34.30%
Argus
Reiterated · Buy · 2019-02-25
—
—
Argus Research
Reiterated · Buy · 2019-02-25
$70.00
−40.10%
Gabelli & Co.
Upgraded · Hold → Buy · 2019-01-24
—
—
Leerink Swann
Reiterated · Market Perform → Perform · 2018-09-25
—
—
Raymond James
Upgraded · Market Perform → Outperform · 2017-09-11
$152.00
+30.10%
PiperJaffray
Downgraded · Overweight → Neutral · 2017-04-17
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2016-08-05
—
—
Brean Capital
Reiterated · Buy · 2016-02-12
—
—
Bank of America
Reiterated · Buy · 2015-05-29
—
—
Lazard
Upgraded · Neutral → Buy · 2013-01-14
—
—
Canaccord Genuity
Reiterated · Buy · 2012-04-26
$152.00
+30.10%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space